Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Citations Over TimeTop 1% of 2021 papers
Abstract
The efficacy and synthetic versatility of asymmetric organocatalysis have contributed enormously to the field of organic synthesis since the early 2000s. As asymmetric organocatalytic methods mature, they have extended beyond the academia and undergone scale-up for the production of chiral drugs, natural products, and enantiomerically enriched bioactive molecules. This review provides a comprehensive overview of the applications of asymmetric organocatalysis in medicinal chemistry. A general picture of asymmetric organocatalytic strategies in medicinal chemistry is firstly presented, and the specific applications of these strategies in pharmaceutical synthesis are systematically described, with a focus on the preparation of antiviral, anticancer, neuroprotective, cardiovascular, antibacterial, and antiparasitic agents, as well as several miscellaneous bioactive agents. The review concludes with a discussion of the challenges, limitations and future prospects for organocatalytic asymmetric synthesis of medicinally valuable compounds.
Related Papers
- → Catalytic Enantioselective α‐Oxysulfonylation of Ketones Mediated by Iodoarenes(2008)125 cited
- → Organocatalytic Enantioselective Desymmetrization of Prochiral 2,2‐Disubstituted Cyclic 1,3‐Diones(2021)26 cited
- → Promising Antiparasitic Natural and Synthetic Products from Marine Invertebrates and Microorganisms(2023)17 cited
- → Enantioselective Desymmetrizations Promoted by Bifunctional Organocatalysts(2014)21 cited
- Antiparasitic agents part vi. synthesis of 7 chloro 4 substituted phenylamino and 7 chloro 4 4 substituted piperazin 1 ylquinolines as potential antiparasitic agents(1987)